Rare diseases
Investigational molecules
Locations
Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
RomaniaA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
RomaniaA study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.
RomaniaA study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism
RomaniaStudy of the effects of ibutamoren mesilate in prepubertal children with growth hormone deficiency
RomaniaA study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder
RomaniaStudy of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment
RomaniaStudy of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery
RomaniaStudy on COR-1167 for Patients with Worsening Heart Failure
RomaniaStudy Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
RomaniaStudy on the Effectiveness of Telitacicept for Adults with Moderate to Severe Systemic Lupus Erythematosus
RomaniaStudy on Cefepime and Enmetazobactam for Children with Complicated Urinary Tract Infections, Including Acute Pyelonephritis
RomaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
